🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07438418
Starting soon Observational

An Observational Study on Gastric Cancer in High-risk Individuals

NCT07438418 · tracked via the Priya Life Science China tracker
Sponsor
Fudan University
Phase
Observational
Started
2026-01-31
Last updated
2026-02-27

Condition(s) studied

Gastric Adenocarcinoma

Investigational drug(s) / intervention(s)

The result of fecal multi-target DNA testing

The result of fecal multi-target DNA testing: By prospectively following individuals who are positive and negative for fecal multi-target testing with baseline negative gastric endoscopy, the incidence of gastric cancer and the progression of gastric precancerous lesions were compared between the two groups.

Study summary

This study is designed as a prospective observational cohort study, aiming to assess the differences in the occurrence of gastric cancer and the progression of gastric cancer-related precancerous lesions between individuals who test positive or negative for fecal multi-target testing, with baseline negative gastric endoscopy results. The clinical outcomes between the two groups will be compared through long-term follow-up.

Eligibility

Sex
ALL
Min age
40 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria : 1. Age ≥ 40 years, gender is not limited. 2. Able and willing to provide informed consent and willing to undergo baseline and follow-up examinations. Exclusion Criteria: 1. A history of diagnosed gastric cancer or other malignant tumors of the digestive tract. 2. Comorbid severe underlying conditions (e.g., severe cardiopulmonary insufficiency, liver or renal failure, etc.) that are likely to result in a short life expectancy or render long-term follow-up impractical. 3. Severe mental illness or incapacity to participate in the study due to lack of civil behavior. 4. Pregnant or breastfeeding women. 5. Other conditions that the investigator deems inappropriate for participation in the study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
People's Hospital of Tongling City Tongling China

More Fudan University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07438418 on ClinicalTrials.gov ↗ ← All trials in China